Pivotal bioVenture Partners Investment Advisor’s Inozyme Pharma INZY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18M | Hold |
|
|||||
|
2025
Q1 | $4.09M | Hold |
|
|||||
|
2024
Q4 | $12.5M | Hold |
|
|||||
|
2024
Q3 | $23.5M | Hold |
|
|||||
|
2024
Q2 | $20M | Hold |
|
|||||
|
2024
Q1 | $34.4M | Hold |
|
|||||
|
2023
Q4 | $19.1M | Hold |
|
|||||
|
2023
Q3 | $18.9M | Buy |
|
|||||
|
2023
Q2 | $20.4M | Buy |
|
|||||
|
2023
Q1 | $18.4M | Buy |
|
|||||
|
2022
Q4 | $2.79M | Hold |
|
|||||
|
2022
Q3 | $7.13M | Hold |
|
|||||
|
2022
Q2 | $12.7M | Buy |
|
|||||
|
2022
Q1 | $6.51M | Hold |
|
|||||
|
2021
Q4 | $10.9M | Hold |
|
|||||
|
2021
Q3 | $18.4M | Hold |
|
|||||
|
2021
Q2 | $27.1M | Hold |
|
|||||
|
2021
Q1 | $31.5M | Hold |
|
|||||
|
2020
Q4 | $32.8M | Buy |
|